drugset / Trial / NCT01496469

Effect of Febuxostat on Blood Pressure

NCT01496469

Phase 2 Completed 121 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of febuxostat, once daily (QD), compared to placebo on lowering ambulatory 24-hour mean blood pressure of participants with hypertension and hyperuricemia (not associated with gout).

Timeline

Start
2012-02
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Febuxostat Small molecule 80 mg Oral

Indications